Patent Assignment
Reel/Frame 060122/0719
Assignment of Assignor's Interest
Recorded: 2022-06-07
Pages: 8
Assignor
SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
Executed: 2022-05-11
Assignee
WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
ROOM 315, MEILIANG ROAD NO. 88, MASHAN, BINHU DISTRICT, WUXI, JIANGSU, 214000, CHINA
Covered Property
(1)
1,2-Dihydro-3H-Pyrazolo[3,4-D]Pyrimidin-3-One Derivative as WEE1 Inhibitor
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.